$IOVA 🗞️ AstraZeneca holds talks with Bristol Myers Squibb (BMS) on $400 billion megadeal, according to the Financial Times.
https://t.co/UBFUyCiIbl
The most likely acquirers of IOVA continue to be, in order, Merck, Roche, Pfizer and AstraZeneca.
Some may realise that